Rare Medications Coverage in the Netherlands: P...

By Staff Writer

August 15, 2025

Zorginstituut Nederland has announced that two rare disease medications, exagamglogene autotemcel (Casgevy®) and omaveloxolon (Skyclarys®), will only be covered by Dutch basic health insurance if their prices drop significantly. For omaveloxolon, ...
Sanofi’s Rilzabrutinib Receives Orphan Designation for IgG4-Related Dis...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...
FDA Approved Eye Drops: Lenz Therapeutics Launches VIZZ for Presbyopia Treatment
Donanemab Alzheimer’s Approval: A New Era in Treatment
AI in Real-World Evidence: Insights from Mitch Higashi
Navigating AI Act Implementation Challenges in MedTech
Thimerosal Vaccine Removal: HHS Finalizes Decision
Facilitators and Barriers in AI Medical Imaging Implementation: A Systematic ...
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
Revolutionizing Pathology: The GAS Intraoperative Diagnosis Platform